Search results for:

ciprofloxacin

ciprofloxacin
Brand names: Cipro
Form Strength
SOLUTION, INTRAVENOUS 200 mg/100 mL; 400 mg/200 mL
TABLET, ORAL 250 mg; 500 mg


Medication comments:
Per policy, these drugs are subject to renal dosing adjustments by pharmacy. 
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
ciprofloxacin IV
(Cipro©)
200-400 mg q8-12h
q8h for pseudomonas
CrCl ≥ 30: No adjustment necessary
CrCl <30: 200-400 mg q24h
HD/PD: 200-400 mg q24h
ciprofloxacin PO
(Cipro©)
250-750 mg q12h CrCl > 50: No adjustment necessary
CrCl 30-50: 250-500 mg q12h
CrCl <30: 500 mg q24h
HD/PD: 250-500 mg q24h
Per policy, these drugs may be converted from IV to PO in patients who meet criteria.  
Generic
(Brand)
Population IV Dose PO Dose Notes
ciprofloxacin
(Cipro)
adult 200 mg IV q12h 250 mg PO q12h Avoid concurrent divalent and trivalent cation administration 2 hours before or 6 hours after. Avoid administration with tube feeds.
200 mg IV q24h 250 mg PO q24h
400 mg IV q8h 750 mg PO q12h
400 mg IV q12h 500 mg PO q12h
400 mg IV q24h 500 mg PO q24h
pediatric 10-15 mg/kg q8-12h
(max: 400 mg/dose or
40 mg/kg/day)
10-15 mg/kg q8-12h
(max: 750 mg/dose or
40 mg/kg/day)
Enteral Drug Administration notes.
Generic
(Brand)
Comments and Considerations Recommendations for Administration with Enteral Nutrition
ciprofloxacin
(Cipro)
Binds to divalent ions (absorption reduced by 50%) Recommend changing to IV for severe infections. For mild/moderate infections suggest 750 mg BID. Use crushed tablets (suspension may NOT be used with any feeding tube). Consider holding continuous EN for 1-2 hours before and after
2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults.
Medication: ciprofloxacin (Cipro)
Criteria 5: medications that should be avoided or have their dosage reduced with varying levels of kidney function in older adults. (Table 6)
CrCl (mL/min) at which action is required <30
Rationale Increased risk of CNS effects (e.g., seizures, confusion) and tendon ruPture.
Recommendation Dosages used to treat common infections typically require reduction when CrCl <30 mL/min.
 Quality of evidence: Moderate, Strength of Recommendation: Strong

Last updated: Sep. 18, 2025



Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.